Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively treats baldness but may cause sexual side effects.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

The document discusses new insights into how hormones affect male sexual health and related conditions.

Finasteride can cause lasting erectile dysfunction, low libido, and depression in some patients.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Serum IMA levels may be linked to premature hair graying and erectile dysfunction.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Men with type 2 diabetes often have low testosterone and signs of hypogonadism, especially if they are overweight.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

Patients should consult urologists for evidence-based erectile dysfunction treatments.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Men with prediabetes have worse sexual health and a higher risk of severe erectile dysfunction.

Many patients with lower urinary tract symptoms also have undiagnosed erectile dysfunction, which improves with treatment.

Testosterone levels are not linked to erectile dysfunction in young and middle-aged men with HIV.